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Abstract
This study was aimed to determine and compared the total cholesterol and C-reactive protein (CRP) levels 
as a prognosis in urosepsis patients treated at the RSUD. Dr. Soetomo Hospital. There were 30 patients 
involved in this study and was assigned to the test for total cholesterol and CRP level at the day of admission, 
three days later, and on the last day (14th days) of sepsis or on the day of the death. The variables were 
tested using the Spearman’s rho test with software SPSS 20. This study found 15 patients who were in septic 
condition, 14 patients had severe sepsis and one patient had septic shock. There were statistically significant 
between total cholesterol and CRP levels in determining the outcome of urosepsis patient. The coefficient 
correlation of total cholesterol was better than CRP. The low total cholesterol levels and high CRP levels can 
be used as predictors of worsening urosepsisprognosis. Total cholesterol levels showed better performance 
than CRP as a prognostic marker for urosepsis.
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Introduction
Urosepsis was a sepsis that originates from urinary 
tract infections with symptoms of SIRS1.Sepsis that was 
not adequately treated can fall under severe sepsis with 
MODS and even septic shock2,3. The sepsis can change 
body hemodynamics, hematology and metabolism 
body by involving immune system responses and many 
organ systems1,4. In severe sepsis and septic shock 
there can be circulatory distress syndrome at the micro 
and mitochondrial levels. Hemodynamic and severe 
circulation disorders can cause disruption of oxygen 
transport and cell respiration which can cause failure 
of many organs. Mitochondrial dysfunction plays an 
important role in sepsis where the rate of mitochondrial 
respiration dysfunction was related to the patient’s 
outcome. Mitochondrial failure associated with sepsis 
role in respiratory distress, especially in areas of hypoxia 
and can cause distress networks that can progress to 
organ dysfunction5,6.
There were several clinical and laboratory variables 
that can be used as markers to determine and assess the 
severity of sepsis and determine its prognosis. One of 
them was total cholesterol. Cholesterol involvement in 
this sepsis condition allows cholesterol to be used as a 
biomarker for urosepsis. Decrease in total cholesterol in 
sepsis occurs from the first time bacterial toxins enter 
the patient’s blood (host) and will further reduce the 
decrease in patients with severe sepsis accompanied by 
MODS7,8.
The reduction in total cholesterol was basically a 
decrease in HDL cholesterol, LDL cholesterol and VLDL 
cholesterol. The total cholesterol was decrease due to 
multi factorial factors including increased cholesterol 
usage in the sepsis process, decreased synthesis and 
changes in metabolism 9,10,11. The use of cholesterol in 
sepsis occurs since bacterial toxins enter the patient’s 
body. Both endotoxins (lipopolysaccharides) from 
gram-negative bacteria and lipoteichoic acid (LTA) 
from gram-positive bacteria will bond between 
lipopolysaccharide (LPS) and cholesterol (lipoprotein) 
known as lipopolysaccharide binding protein (LBP)12,13. 
This cholesterol bond with lipopolysaccharide (LBP) 
aims to neutralize germ toxins and reduce cellular 
response caused by gram-negative and gram-positive 
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bacteria10, 14.  In addition to reduce the cellular response 
of the host to endotoxin, LBP also aims to present 
endotoxin monomers (LPS) in membrane bound CD 14 
in monocytes, neutrophils and macrophages15, 16.Thus, 
the invasion of germs can be prevented and overcome 
4,17. Decreased cholesterol synthesis in liver also occurs 
in sepsis, thiswas related to an increase in cytokine 
mediators in the form of TNF α, IL-1 and interleukin 
610. Decreased lipoprotein (cholesterol) was seen after 
liver cells were exposed to TNF α, IL-1 and IL-6. This 
study was aimed to determine and compared the total 
cholesterol and C-reactive protein (CRP) levels as a 
prognosis in urosepsis patients treated at the RSUD. Dr. 
Soetomo Hospital.
Methodology
This study was a prospective study of the type of 
diagnostic test which highlight on the comparison of 
total cholesterol levels and C-reactive protein (CRP) 
in assessing urosepsisprognosis through observational 
analytic research designs. The study sample focused on 
the patients who were diagnosed with urosepsis (sepsis 
caused by urinary tract infection).and treated at the RSUD. 
Dr. Soetomo Hospital. The sampleswas calculated based 
on the formula of the sample size for correlative analytic 
test research. All respondentswere required to sign an 
approval sheet following the research. On the first day, 
the respondentswere classified based on the results of 
assessment for clinical severity, total cholesterol, CRP, 
MAP, blood leukocytes, urinalysis, urine culture and 
blood culture, BGA (blood gas analysis), SGOT, SGPT, 
BUN, and serum creatinine level. On the third day the 
patients were reassessed for their clinical severity, total 
cholesterol, and CRP. Patients were continuing follow 
this study until the last day of the patient’s death, 
recovery or a maximum of 14 days of treatment. The 
correlation test was performed between total cholesterol 
and CRP results on the outcome / prognosis of the 
urosepsis patient.
The results of the study werecollected and processed 
with the SPSS program. The statistical test used was a 
bivariate correlation test between total cholesterol and 
CRP against the prognosis (outcome) of patients with 
the Spearman’s rho test. The correlation coefficients of 
each variable was determined to compare the correlation 
strength between CRP and blood cholesterol against the 
prognosis (outcome) of patients with urosepsis.
Result and Discussion
Table 1 showed the CRP score and total cholesterol 
based on outcome. The average results of the first day 
CRP examination in patients was 177.18 ± 107.37 mg/L, 
worsening 146.74 ± 62.82 mg/L, whereas in patients 
with improved outcome showed low average CRP score 
which was 88.10 ± 74.41 mg/L. The mean CRP values 
on the third and last day of patients with clinically 
improved decreased from 56.28 ± 50.15 mg/L to 31.58 
± 37.37 mg/L. The mean CRP of patients died on the 
third day was 127.10 ± 106.28 mg/L and on the last day 
was 141.88 ± 105.61 mg/L. The difference (Δ) of CRP 
between last day and first day showed positive value in 
the patient with outcome deteriorated which was 38.76 
± 59.02 mg/L, while the negative value in the patient 
improved and died were -56.52 ± 70.20 mg/L and -35.3 
± 97.53 mg/L respectively.
Examination of total cholesterol based on outcome 
at the end of the study showed lowest average total 
cholesterol examination results on the first day in 
patients with death outcomes that was equal to 63.25 ± 
14.15 mg/dL and then increased follow by worsening 
patients which was 101.38 ± 20.51 mg/dL and improved 
patients which was  119.5 ± 17.81 mg/dL.Meanwhile, 
patients with outcome worsening and dying clearly seen 
total cholesterol values continued to decline. In patients 
worsening the total cholesterol value for the third day 
was 93.62 ± 10.68 mg/dL and the last day was 82.25 
± 10.9 mg/dL. In patients who died in third day, total 
cholesterol value was 56.0 ± 6.98 mg/dL and the last day 
was 51.0 ± 6.16 mg/dL. The difference (Δ) of cholesterol 
between the last day and first day showed positive 
mean value which was 35.3 ± 21.46 mg/dL for patients 
improved. While, negative mean values in patients who 
worsened and died were -19.13 ± 18.45 mg/dL and 
-12.25 ± 11.59 mg/dL.
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Table 1. CRP levels and total cholesterol based on outcome
Criteria
Improved Worsening Died
n Mean SD n Mean SD n Mean SD
1st CRP (mg/L) 18 88.10 74.41 8 146.74 62.82 4 177.18 107.37
3rd CRP (mg/L) 18 56.28 50.15 8 148.88 63.15 4 127.10 106.28
14th CRP (mg/L) 18 31.58 37.37 8 185.50 88.71 4 141.88 105.61
Δ(14th CRP - 1st CRP) (mg/L) 18 -56.52 70.20 8 38.76 59.02 4 -35.3 97.53
1st Chol (mg/dL) 18 119.50 17.81 8 101.38 20.51 4 63.25 14.15
3rd Chol (mg/dL) 18 128.61 23.61 8 93.62 10.68 4 56.00 6.98
14th Chol (mg/dL) 18 154.83 25.71 8 82.25 10.9 4 51 6.16
Δ(14th Chol -1st Chol) (mg/dL) 18 35.3 21.46 8 -19.13 18.45 4 -12.25 11.59
The correlation test was performed using Spearman’s rho method in order to determine the significance and 
strength of correlation (correlation coefficient). Correlation test was performed between first day CRP, third day CRP, 
last day CRP, delta (Δ) CRP (14th CRP – 1st CRP), total cholesterol of first day, third day, last day, and delta (Δ) 
total cholesterol (Δ 14th Chol -1st Chol)) against the outcome of patients with urosepsis. CRP and total cholesterol 
statistical tests were conducted in all study samples. All study samples were observed and assessed on the outcome 
or the condition of the patient until the last day the patient was declared cured or died. 
Table 2. Results of the Correlation Test of CRP levels with the outcome using the Spearman’s rho formula 
(n = all samples)
1st day CRP 3rd days CRP 14th days CRP Δ CRP Outcome
1st day CRP
Correlation 
coefficient
1.000 0.795** 0.694** -0.171 .459*
Sig. (2-tailed) . 0.000 0.000 0.366 .011
N 30 30 30 30 30
3rd days 
CRP
Correlation 
coefficient
0.795** 1.000 0.849** 0.202 0.543**
Sig. (2-tailed) 0.000 . 0.000 0.283 0.002
N 30 30 30 30 30
14th days 
CRP
Correlation 
coefficient
0.694** 0.849** 1.000 .443* 0.686**
Sig. (2-tailed) 0.000 0.000 . 0.014 0.000
N 30 30 30 30 30
Δ CRP
Correlation 
coefficient
-0.171 0.202 0.443* 1.000 0.365*
Sig. (2-tailed) 0.366 0.283 .014 . 0.047
N 30 30 30 30 30
* Correlation was significant at the 0.05 level (2-tailed)
** Correlation was significant at the 0.01 level (2-tailed)
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Based on Table 3, the value of the correlation test of CRP levels on outcome in patients with urosepsis using 
the Spearman’s rho formula was shown in Table 3. Based on statistical tests it was found that CRP levels on the 
first, third, fourteen days, and delta CRP (day 14 minus the first day) in patients with urosepsis showed a significant 
correlation (p <0.05) to the outcome with a significance value of 0.011, 0.002, 0,000 and 0.047 respectively and the 
correlation coefficients (r) were 0.459, 0,543, 0.686, and 0.365 respectively.
Table 3. Results of Correlation Test of Total Cholesterol Level with outcome using Spearman’s rho formula 
(n = all samples)
1st day Chol 3rd days Chol 14th days Chol Δ Chol Outcome
1st day 
Chol
Correlation 
coefficient
1.000 0.786** 0.769** 0.359 -0.633**
Sig. (2-tailed) . 0.000 0.000 0.051 0.000
N 30 30 30 30 30
3rd days 
Chol
Correlation 
coefficient
0.786** 1.000 0.928** 0.716** -0.755**
Sig. (2-tailed) 0.000 . 0.000 0.000 0.000
N 30 30 30 30 30
14th days 
Chol
Correlation 
coefficient
0.769** 0.928** 1.000 .826** -0.874**
Sig. (2-tailed) 0.000 0.000 . 0.000 0.000
N 30 30 30 30 30
Δ Chol
Correlation 
coefficient
0.359 0.716** 0.826** 1.000 -0.754**
Sig. (2-tailed) 0.051 0.000 0.000 - 0.000
N 30 30 30 30 30
* Correlation was significant at the 0.05 level (2-tailed)
** Correlation was significant at the 0.01 level (2-tailed)
Table 4 illustrated the strength of the correlation which assessed through the magnitude of the correlation 
coefficient (r). The correlation was stronger if the r value approaches 1 or -1. From the results of statistical tests 
obtained the value of the correlation coefficient (r) of CRP versus cholesterol on the first day was (0.459 VS -0.633), 
the third day was (0.543 VS -0.755), the last day was (0.686 VS – 0.874) and Δ CRP compared to cholesterol was 
(0.365 vs -0.754).
Table 4. Strength of correlation of CRP compared to total cholesterol against outcome
Variable 
Significant (p) Correlation coefficient (r)
CRP Chol CRP Chol
1st day 0.011 0.000 0.459 -0.633
3rd day 0.002 0.000 0.543 -0.755
14th day 0.000 0.000 0.686 -0.874
Delta 0.047 0.000 0.365 -0.754
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Discussion
Increased CRP levels require a minimum of 12-
18 hours and CRP increased slowly during sepsis and 
reaches peak levels in 36-50 hours. The concentration will 
drop rapidly with a half-life of 19 hours if the stimulus 
was removed. This causes CRP to be independent and 
only affected by therapy and actions to eliminate the 
inflammatory process. In this study, 4 patients died with 
varying initial CRP levels of 53.0 mg /L, 156.0 mg /L, 
186 mg /L and 313.7 mg /L. The high level of CRP can 
be a description of the number of organ systems that 
have failed their function18.
In this study, the first day CRP levels in patients with 
improved outcomes had the lowest average compared 
to the first day CRP levels in patients with worsening 
and dying outcomes, which was 88.10 ± 74.41 mg /L 
compared to 146.74 ± 62.82 mg /L and 177.18 ± 107.37 
mg /L. On the third and final day examination, a very 
clear pattern was seen that in patients with improved 
outcomes there was a lower CRP level of 56.28 ± 50.15 
mg /L and 31.58 ± 37.37 mg /L. Whereas the worsening 
of patients continued to increase, 148.88 ± 63.15 mg /L 
on the third day and 185.50 ± 88.71 mg /L on the last 
day. In patients with death outcomes, the mean on third 
day CRP level was 127.10 ± 106.28 mg /L and on the last 
day it increased to 141.88 ± 105.61 mg /L. The results 
of the correlation test of CRP levels with the outcome 
obtained significant values (p <0.05) on the examination 
for the first, third, and last days were 0.459, 0,543, and 
0.686 respectively. These results reflect that low CRP 
levels were associated with a good prognosis, whereas 
high CRP levels were associated with a poor prognosis 
even to death both on the first day, third day and last day 
examination. 
This study was determined that total cholesterol and 
CRP concentration can be used as predictors of outcome 
and prognosis of urosepsis. Serial total cholesterol and 
CRP measurement (periodically) will be more helpful in 
identifying the patient’s condition so that it can provide 
additional information to increase the aggressiveness of 
the action to be given. From the results of data analysis 
in this study it can also be determined that the total 
cholesterol level compared to CRP showed a higher 
correlation with the outcome of patients with urosepsis. 
So that the measurement of total cholesterol levels in 
patients with urosepsis was better in predicting outcome 
or prognosis when compared with CRP levels.
Conclusion
In conclusions, total cholesterol levels can be used 
as a marker of prognosis (improved / worsened / died) 
in urosepsis patients both on the first, third, and last day 
examination with a significant correlation (p <0.05). The 
lower the total cholesterol level the worse the prognosis 
of the patient and vice versa.CRP levels can be used as 
a marker of prognosis (improved / worsened / died) in 
urosepsis patients both on the first, third, and last day 
examination with a significant correlation (p <0.05). 
The higher the CRP level the worse the prognosis of the 
patient and vice versa. Plasma total cholesterol levels 
showed a greater correlation coefficient than CRP levels 
on patient outcomes with urosepsis both on the first day 
examination (-0.633 vs. 0.459), third (-0.755 vs 0.543), 
and the last day (-0.874 vs 0.686). So that total plasma 
cholesterol levels can be used as a better prognosis 
indicator than CRP levels.
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